Intradiscal PRP for Discogenic Low Back Pain: Evidence Summary
Various (Guidelines) · Multiple/Clinical Guidelines (2025)
Intradiscal PRP injection for discogenic low back pain represents one of the newest and most experimental applications of PRP in orthopedics. Current evidence is limited to small pilot studies, case series, and clinical guidelines listing it as an emerging indication. The theoretical basis is sound: PRP growth factors could stimulate repair in the avascular intervertebral disc. LP-PRP is strongly recommended to avoid inflammatory reactions in the confined, avascular disc space. Fluoroscopy-guided injection is the standard delivery method.
Clinical Relevance
Clinicians should consider intradiscal PRP as investigational only. While the biological rationale is compelling, the evidence base is insufficient to recommend routine use. Patients should be counseled that this is an off-label, experimental application. LP-PRP formulations are essential for this application.
Key Takeaways
- EXPERIMENTAL indication with very limited high-quality evidence
- LP-PRP strongly preferred due to avascular disc environment (leukocytes could worsen inflammation)
- Fluoroscopy guidance required for safe intradiscal delivery
- Small pilot studies show promising pain reduction
- Additional indications include facet arthropathy and sacroiliac joint dysfunction
- Large RCTs are needed before recommending clinical adoption
Key Findings
EXPERIMENTAL indication with VERY LIMITED evidence. Small pilot studies promising. LP-PRP strongly preferred. Large RCTs needed.
Clinical Context
Study Design
Evidence Summary/Clinical Guidelines
Condition
Discogenic Low Back Pain
Primary Outcome
VAS, Functional Disability Indices
PRP Protocol & Intervention
Preparation System
Various
Leukocyte Status
LP-PRP recommended (avascular disc)
Injection Volume
1 mL
Injection Frequency
1 injection(s)
Guidance Method
Fluoroscopy-guided intradiscal